Omeros reported $91.35M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 51.75M 7.22M
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Adma Biologics ADMA:US $ 174.78M 3.43M
Aerie Pharmaceuticals AERI:US $ 275.95M 13.07M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Cytokinetics CYTK:US $ 494.94M 130.71M
Dynavax Technologies DVAX:US $ 852.67M 268.76M
Gilead Sciences GILD:US $ 14200M 275M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Insmed INSM:US $ 958.98M 79.21M
Knight Therapeutics Inc GUD:CN C$ 343.07M 13.04M
Macrogenics MGNX:US $ 334.7M 32.3M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Omeros OMER:US $ 91.35M 21.05M
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Rockwell Medical RMTI:US $ 46.08M 6.32M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
United Therapeutics UTHR:US $ 2385.9M 68M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Vital Therapies VTL:US $ 122.5M 20.81M
Xoma XOMA:US $ 74.87M 12.38M